Stoke Therapeutics, Inc. (STOK) SEC filings
STOK SEC filings moved a median of +0.17% by the close. STOK SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the STOK overview →
71 measured STOK SEC filing events.
Where these STOK SEC filings landedvs 71 measured STOK SEC filing reactions
| Middle 50% of STOK SEC filing reactions | -3.76% to +2.95% |
|---|---|
| Median reaction (to close) | +0.17% |
| Measured reactions | 71 |
Point-in-time · zero look-ahead
Half of the 71 STOK SEC filing events with a measured close landed between -3.76% and +2.95%; 54% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Stoke Therapeutics, Inc. For: Sep 22 | SEC filing · Form 8-K | -0.41% | +4.04% | |
| Form 10-Q Stoke Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.45% | +10.04% | |
| Form 8-K Stoke Therapeutics, Inc. For: Aug 03 | SEC filing · Form 8-K | +0.45% | +10.04% | |
| Form S-8 Stoke Therapeutics, Inc. | SEC filing · Form S-8 | +0.45% | +10.04% | |
| Form 8-K Stoke Therapeutics, Inc. For: Jun 30 | SEC filing · Form 8-K | +0.30% | -0.55% | |
| Form 8-K Stoke Therapeutics, Inc. For: Jun 03 | SEC filing · Form 8-K | -1.29% | -0.43% | |
| Form 10-Q Stoke Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.52% | +3.04% | |
| Form 8-K Stoke Therapeutics, Inc. For: May 07 | SEC filing · Form 8-K | +1.52% | +3.04% | |
| Form ARS Stoke Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | -1.29% | -3.80% | |
| Form DEF 14A Stoke Therapeutics, Inc. For: Jun 03 | SEC filing · Form DEF | -1.29% | -3.80% | |
| Form DEFA14A Stoke Therapeutics, Inc. | SEC filing · Form DEFA14A | -1.29% | -3.80% | |
| Form 8-K Stoke Therapeutics, Inc. For: Apr 03 | SEC filing · Form 8-K | +1.39% | +0.69% | |
| Form 8-K Stoke Therapeutics, Inc. For: Mar 23 | SEC filing · Form 8-K | -2.06% | -3.73% | |
| Form S-3ASR Stoke Therapeutics, Inc. | SEC filing · Form S-3ASR | -0.13% | +10.67% | |
| Form 10-K Stoke Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.55% | -0.06% | |
| Form S-8 Stoke Therapeutics, Inc. | SEC filing · Form S-8 | +0.55% | -0.06% | |
| Form 8-K Stoke Therapeutics, Inc. For: Feb 13 | SEC filing · Form 8-K | -3.17% | +0.03% | |
| Form 8-K Stoke Therapeutics, Inc. For: Jan 21 | SEC filing · Form 8-K | +2.46% | +0.89% | |
| Form 8-K Stoke Therapeutics, Inc. For: Jan 11 | SEC filing · Form 8-K | -5.11% | +7.37% | |
| Form 8-K Stoke Therapeutics, Inc. For: Dec 05 | SEC filing · Form 8-K | +0.20% | +0.20% | |
| Form 8-K Stoke Therapeutics, Inc. For: Dec 05 | SEC filing · Form 8-K | +0.93% | -0.83% | |
| Form 10-Q Stoke Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -6.61% | +4.01% | |
| Form 8-K Stoke Therapeutics, Inc. For: Nov 04 | SEC filing · Form 8-K | -6.61% | +4.01% | |
| Form 8-K Stoke Therapeutics, Inc. For: Oct 05 | SEC filing · Form 8-K | +0.58% | -0.15% | |
| Form 8-K/A Stoke Therapeutics, Inc. For: Jun 03 | SEC filing · Form 8-K | -1.71% | -2.05% | |
| Form 10-Q Stoke Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -8.80% | +13.57% | |
| Form 8-K Stoke Therapeutics, Inc. For: Aug 12 | SEC filing · Form 8-K | -8.80% | +13.57% | |
| Form 8-K Stoke Therapeutics, Inc. For: Aug 11 | SEC filing · Form 8-K | -0.46% | +0.77% | |
| Form EFFECT Stoke Therapeutics, Inc. | SEC filing · Form EFFECT | +0.68% | +1.94% | |
| Form 8-K Stoke Therapeutics, Inc. For: Jul 10 | SEC filing · Form 8-K | -2.12% | +0.17% | |
| Form S-3 Stoke Therapeutics, Inc. | SEC filing · Form S-3 | -2.12% | +0.17% | |
| Form S-8 Stoke Therapeutics, Inc. | SEC filing · Form S-8 | -2.12% | +0.17% | |
| Form 8-K Stoke Therapeutics, Inc. For: Jun 03 | SEC filing · Form 8-K | -0.83% | -0.09% | |
| Form 8-K Stoke Therapeutics, Inc. For: Jun 04 | SEC filing · Form 8-K | +1.70% | +0.46% | |
| Form 10-Q Stoke Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.78% | +3.21% | |
| Form 8-K Stoke Therapeutics, Inc. For: May 13 | SEC filing · Form 8-K | -5.17% | -14.46% | |
| Form ARS Stoke Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +0.30% | +1.28% | |
| Form DEF 14A Stoke Therapeutics, Inc. For: Jun 03 | SEC filing · Form DEF | +0.30% | +1.28% | |
| Form DEFA14A Stoke Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.30% | +1.28% | |
| Form 10-K Stoke Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.79% | -7.71% | |
| Form 8-K Stoke Therapeutics, Inc. For: Mar 18 | SEC filing · Form 8-K | -2.38% | +2.78% | |
| Form S-8 Stoke Therapeutics, Inc. | SEC filing · Form S-8 | -1.79% | -7.71% | |
| Form 8-K Stoke Therapeutics, Inc. For: Feb 14 | SEC filing · Form 8-K | -3.06% | -5.10% | |
| Form 8-K Stoke Therapeutics, Inc. For: Jan 07 | SEC filing · Form 8-K | +2.44% | -5.19% | |
| Form 8-K Stoke Therapeutics, Inc. For: Dec 04 | SEC filing · Form 8-K | +1.93% | +5.93% | |
| Form 10-Q Stoke Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.68% | -3.29% | |
| Form 8-K Stoke Therapeutics, Inc. For: Nov 05 | SEC filing · Form 8-K | -0.80% | -0.31% | |
| Form S-3ASR Stoke Therapeutics, Inc. | SEC filing · Form S-3ASR | -0.43% | -0.87% | |
| Form 8-K Stoke Therapeutics, Inc. For: Sep 10 | SEC filing · Form 8-K | -1.01% | -6.94% | |
| Form 10-Q Stoke Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.35% | -0.70% | |
| Form 8-K Stoke Therapeutics, Inc. For: Aug 07 | SEC filing · Form 8-K | -2.63% | -8.72% | |
| Form 8-K Stoke Therapeutics, Inc. For: Jun 18 | SEC filing · Form 8-K | +0.14% | +2.43% | |
| Form EFFECT Stoke Therapeutics, Inc. | SEC filing · Form EFFECT | +1.01% | -4.30% | |
| Form S-3 Stoke Therapeutics, Inc. | SEC filing · Form S-3 | +0.82% | -4.41% | |
| Form 8-K Stoke Therapeutics, Inc. For: Jun 05 | SEC filing · Form 8-K | +0.61% | +0.68% | |
| Form 10-Q Stoke Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.68% | +0.51% | |
| Form 8-K Stoke Therapeutics, Inc. For: May 06 | SEC filing · Form 8-K | +1.17% | -1.25% | |
| Form 8-K Stoke Therapeutics, Inc. For: Apr 29 | SEC filing · Form 8-K | +0.13% | -5.65% | |
| Form ARS Stoke Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +2.06% | +4.29% | |
| Form DEF 14A Stoke Therapeutics, Inc. For: Jun 05 | SEC filing · Form DEF | +2.06% | +4.29% | |
| Form DEFA14A Stoke Therapeutics, Inc. | SEC filing · Form DEFA14A | +2.06% | +4.29% | |
| Form S-8 Stoke Therapeutics, Inc. | SEC filing · Form S-8 | +0.90% | -4.34% | |
| Form 8-K Stoke Therapeutics, Inc. For: Mar 27 | SEC filing · Form 8-K | +0.27% | +2.04% | |
| Form 10-K Stoke Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +9.77% | -7.05% | |
| Form 8-K Stoke Therapeutics, Inc. For: Mar 25 | SEC filing · Form 8-K | +9.77% | -7.05% | |
| Form 8-K Stoke Therapeutics, Inc. For: Jan 08 | SEC filing · Form 8-K | +0.00% | +2.70% | |
| Form 8-K Stoke Therapeutics, Inc. For: Dec 12 | SEC filing · Form 8-K | -0.19% | -2.10% | |
| Form 8-K Stoke Therapeutics, Inc. For: Dec 01 | SEC filing · Form 8-K | +0.91% | +2.87% | |
| Form 10-Q Stoke Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -3.09% | -4.95% | |
| Form 8-K Stoke Therapeutics, Inc. For: Nov 07 | SEC filing · Form 8-K | +0.00% | +12.53% | |
| Form 8-K Stoke Therapeutics, Inc. For: Oct 24 | SEC filing · Form 8-K | +0.00% | -4.26% |
Keep exploring
More STOK: earnings → · analyst actions → · STOK overview →